Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
The City of Hope National Medical Center, Duarte, California Hoag Memorial Hospital, Newport Beach, California Mass General Brigham Cancer Institute, Boston, Massachusetts Dana Farber Cancer Institute, Boston, Massachusetts Memorial Sloan Kettering Cancer Center, New York, New York The University of Texas MD Anderson Cancer Center, Houston, Texas